1-(carbamimidoylsulfanyl)-2-methoxyethane hydrobromide, 95.0%, 1g

Plan phase 20x/0.40 infinity corrected objective

(2S,2'S,3S,3'S)-3,3'-Di-tert-butyl-2,2'-dimethyl-2,2',3,3'-tetrahydro-4,4'-bibenzo[d][1,3]oxaphosphole, 97%, 100mg

3-(3-Chlorophenyl)propionic acid, 98.0%, 1g

tert-Butyl 4-formylpyridin-3-ylcarbamate, 95.0%, 10g

1-(4-Bromophenyl)-1h-pyrazole-3-carboxylic acid, 95%, 1g

Methyl 2-bromoisonicotinate, 98.00%, 25g

Methyl 3-(3-nitrophenyl)propanoate, 97%, 5g

3,3-Difluoropiperidin-4-ol hydrochloride, 95.0%, 5g

8-Fluoroisoquinoline-1-carboxylic acid, 98%, 100mg

4-Bromo-2-((tetrahydro-2H-pyran-4-yl)oxy)pyridine, 95.0%, 1g

Lead(II) iodide 99.999% 50 g

Methyl 2-amino-6-methoxybenzoate, 95.0%, 5g